Bright Minds Biosciences Appoints Drug Development Executive Mark A. Smith M.D., Ph.D. as Chief Medical Officer
— Dr. Smith is a 20-year pharmaceutical industry veteran with extensive central nervous system (“CNS”)…
Month: November 2022
Klaytn Foundation Launches Beta “Klaytn Square” Governance Portal for More Transparent and Decentralized Ecosystem
Beta version of governance portal provides information about Klaytn Governance Council (GC) members, their KLAY…
BeWhere Holdings Inc. Reports Third Quarter 2022 Results
Toronto, Ontario–(Newsfile Corp. – November 23, 2022) – BeWhere (TSXV: BEW) (OTCQB: BEWFF) (“BeWhere” or…
Verint to Announce Third Quarter Financial Results on Wednesday, December 7, 2022
MELVILLE, N.Y.–(BUSINESS WIRE)–Verint®Systems Inc. (NASDAQ: VRNT) will conduct a conference call on Wednesday, December 7,…
Envision Physician Services and Qure.ai Sponsor AI After Dark – An Artificial Intelligence Symposium Featuring Renowned International Radiologists
NASHVILLE, Tenn. & NEW YORK–(BUSINESS WIRE)–Envision Physician Services (part of Envision Healthcare Corporation), a leading…
Avisa Partners Acquires Top Intelligence Firm to Bring Comprehensive Global Investigations Offering to Clients
Acquisition of Forward Risk latest example of Avisa Partners’ High-Growth Expansion Strategy WASHINGTON–(BUSINESS WIRE)–Avisa Partners…
Community Health Systems to Participate in the BofA Securities 2022 Leveraged Finance Conference
FRANKLIN, Tenn.–(BUSINESS WIRE)–Community Health Systems, Inc. (NYSE:CYH) today announced that management will participate in the…
Lineage Opens New Fully Automated Cool Port II High-Rise Cold Storage Facility in the Port of Rotterdam
Lineage has expanded its European network of strategically located cold storage facilities with the opening…
AM Best Upgrades Credit Ratings of AES Global Insurance Company
OLDWICK, N.J.–(BUSINESS WIRE)–#insurance—AM Best has upgraded the Financial Strength Rating to A (Excellent) from A-…
Infovista to showcase innovative solutions to assure success of mission-critical networks at DoDIIS Worldwide Conference
Portfolio of planning, testing and Automated Assurance & Operations assurance solutions enables governmental agencies, operators…
Sirona Biochem Signs International Partnership Agreement with Wanbang Biopharmaceuticals
VANCOUVER, British Columbia, Nov. 23, 2022 (GLOBE NEWSWIRE) — Sirona Biochem Corp. (TSX-V: SBM) (FSE:…
Rakovina Therapeutics to Present at the Emerging Growth Conference on November 30, 2022
VANCOUVER, British Columbia, Nov. 23, 2022 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (“Rakovina”…
Tenaya Therapeutics to Participate in Upcoming Piper Sandler 34th Annual Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Nov. 23, 2022 (GLOBE NEWSWIRE) — Tenaya Therapeutics, Inc. (NASDAQ: TNYA),…
Clearmind Announces Initiation of CMND-100 Manufacturing Program to Address its Upcoming Clinical Trial
VANCOUVER, Nov. 23, 2022 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (CSE: CMND), (FSE:…
Rain Therapeutics Announces a Poster Presentation at the 2022 San Antonio Breast Cancer Symposium
NEWARK, Calif., Nov. 23, 2022 (GLOBE NEWSWIRE) — Rain Therapeutics Inc. (NasdaqGS: RAIN), (Rain), a…
NewAmsterdam Pharma Debuts as Publicly Traded Company Focused on Developing Obicetrapib, a Low-Dose, Once-Daily Oral LDL-Lowering Agent with Promising Safety and Efficacy Clinical Data, as a Potential Preferred Therapy for High Risk Cardiovascular Disease Patients
— Business combination transaction with Frazier Lifesciences Acquisition Corporation, a special purpose acquisition company sponsored…
Oncorus to Participate in Upcoming Investor Conferences
ANDOVER, Mass., Nov. 23, 2022 (GLOBE NEWSWIRE) — Oncorus, Inc. (Nasdaq: ONCR), a viral immunotherapies…
Cidara Therapeutics to Participate in the World Antiviral Congress 2022
SAN DIEGO, Nov. 23, 2022 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology…
Humacyte to Present at the 34th Annual Piper Sandler Healthcare Conference
DURHAM, N.C., Nov. 23, 2022 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology…
Replimune to Present at the Piper Sandler 34th Annual Healthcare Conference
WOBURN, Mass., Nov. 23, 2022 (GLOBE NEWSWIRE) — Replimune Group, Inc. (NASDAQ: REPL), a clinical…